New insider activity at Soligenix ( (SNGX) ) has taken place on October 3, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Christopher Schaber, the Chairman of the Board, CEO, and President of Soligenix, has made a significant move by purchasing 15,132 shares of the company’s stock. This transaction is valued at $19,974, indicating a strong vote of confidence in the company’s future prospects.
Recent Updates on SNGX stock
In the last 24 hours, Soligenix (SNGX) has made significant announcements impacting its stock. The company expanded its European Medical Advisory Board to support its Phase 3 study of HyBryte for cutaneous T-cell lymphoma, aiming for results by the second half of 2026. Additionally, Soligenix raised $7.5 million through a public offering, which closed on September 29, 2025, to fund research and development, extending its cash runway through 2026. Despite these developments, the stock’s performance is under scrutiny due to weak financial metrics, including declining revenues and persistent losses, which have led to a ‘Underperform’ rating by Spark, an AI Analyst. The company’s recent loan repayment is seen as a positive step, but it does not fully address the ongoing financial challenges. Furthermore, Soligenix’s ThermoVax platform showed promising results in vaccine stability, potentially enhancing its product offerings.
Spark’s Take on SNGX Stock
According to Spark, TipRanks’ AI Analyst, SNGX is a Underperform.
Soligenix’s overall stock score is primarily driven by its weak financial performance, characterized by declining revenues and persistent losses. While the technical analysis indicates some potential for short-term stability, the valuation and financial metrics suggest ongoing challenges. The company’s recent loan repayment is a positive step towards financial flexibility, but it does not alleviate the underlying financial and operational issues.
To see Spark’s full report on SNGX stock, click here.
More about Soligenix
YTD Price Performance: -56.46%
Average Trading Volume: 10,723,436
Technical Sentiment Signal: Strong Sell
Current Market Cap: $12.62M